Evidence map›Paper›PMID 33539341›Full record

ArticlePLoS genetics2021

Glucocerebrosidase reduces the spread of protein aggregation in a Drosophila melanogaster model of neurodegeneration by regulating proteins trafficked by extracellular vesicles.

Kathryn A Jewett, Ruth E Thomas, Chi Q Phan, Bernice Lin, Gillian Milstein, Selina Yu, Lisa F Bettcher, Fausto Carnevale Neto, Danijel Djukovic, Daniel Raftery and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Isolation of extracellular vesicles from insect hemolymph.Current research in insect science · 2025
    Review
  5. Review
  6. Mass spectrometry-based proteomics for biomarker discovery in theNeuroprotection (Chichester, England) · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Cells · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kathryn A JewettDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-7029-7132
Ruth E ThomasDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0001-9648-2339
Chi Q PhanDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0001-5190-3910
Bernice LinVA Puget Sound Healthcare System, Seattle, Washington, United States of America.ORCID 0000-0002-3262-5043
Gillian MilsteinDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0003-2825-9623
Selina YuDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-9444-4360
Lisa F BettcherNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0001-6058-9337
Fausto Carnevale NetoNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-9364-933X
Danijel DjukovicNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington, United States of America.
Daniel RafteryNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0003-2467-8118
Leo J PallanckDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-5943-9339
Marie Y DavisVA Puget Sound Healthcare System, Seattle, Washington, United States of America.ORCID 0000-0003-2502-6293
University of Washington · USVA Puget Sound Health Care System · US

Funding

GENETIC APPROACHES TO AGING RESEARCHT32AG000057 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 1985 to 2019
$14.2M
A Drosophila model for studying mechanisms of Gaucher's disease and synucleinopathiesR01NS094252 · NINDS · UNIVERSITY OF WASHINGTON · PI PALLANCK, LEO J · 2015 to 2019
$1.6M
Mechanisms of non-cell-autonomous regulation of brain protein aggregation in DrosophilaR56AG060963 · NIA · UNIVERSITY OF WASHINGTON · PI PALLANCK, LEO J · 2018 to 2019
$778k
Multiplexed UPLC-MS/MS System for Advanced Target MetabolomicsS10OD021562 · OD · UNIVERSITY OF WASHINGTON · PI RAFTERY, DANIEL · 2016 to 2016
$596k
Understanding Susceptibility to Parkinson's Disease due to GBA1 MutationsIK2BX003244 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI DAVIS, MARIE YNEZ · 2017 to 2022
–
BLRD VA IK2 BX003244NIA NIH HHS R56 AG060963NIA NIH HHS T32 AG000057NIH HHS S10 OD021562NINDS NIH HHS R01 NS094252
6 · The paper itself

Abstract

Abnormal protein aggregation within neurons is a key pathologic feature of Parkinson's disease (PD). The spread of brain protein aggregates is associated with clinical disease progression, but how this occurs remains unclear. Mutations in glucosidase, beta acid 1 (GBA), which encodes glucocerebrosidase (GCase), are the most penetrant common genetic risk factor for PD and dementia with Lewy bodies and associate with faster disease progression. To explore how GBA mutations influence pathogenesis, we previously created a Drosophila model of GBA deficiency (Gba1b) that manifests neurodegeneration and accelerated protein aggregation. Proteomic analysis of Gba1b mutants revealed dysregulation of proteins involved in extracellular vesicle (EV) biology, and we found altered protein composition of EVs from Gba1b mutants. Accordingly, we hypothesized that GBA may influence pathogenic protein aggregate spread via EVs. We found that accumulation of ubiquitinated proteins and Ref(2)P, Drosophila homologue of mammalian p62, were reduced in muscle and brain tissue of Gba1b flies by ectopic expression of wildtype GCase in muscle. Neuronal GCase expression also rescued protein aggregation both cell-autonomously in brain and non-cell-autonomously in muscle. Muscle-specific GBA expression reduced the elevated levels of EV-intrinsic proteins and Ref(2)P found in EVs from Gba1b flies. Perturbing EV biogenesis through neutral sphingomyelinase (nSMase), an enzyme important for EV release and ceramide metabolism, enhanced protein aggregation when knocked down in muscle, but did not modify Gba1b mutant protein aggregation when knocked down in neurons. Lipidomic analysis of nSMase knockdown on ceramide and glucosylceramide levels suggested that Gba1b mutant protein aggregation may depend on relative depletion of specific ceramide species often enriched in EVs. Finally, we identified ectopically expressed GCase within isolated EVs. Together, our findings suggest that GCase deficiency promotes accelerated protein aggregate spread between cells and tissues via dysregulated EVs, and EV-mediated trafficking of GCase may partially account for the reduction in aggregate spread.

Indexed as

AnimalsBiological TransportBrainCeramidesDisease Models, AnimalDNA-Binding ProteinsDrosophila melanogasterDrosophila ProteinsExtracellular VesiclesGene Knockdown TechniquesGlucosylceramidaseGlucosylceramidesLipidomicsMusclesMutationNeuronsCeramidesDNA-Binding ProteinsDrosophila ProteinsGlucosylceramidaseGlucosylceramidesProteomeref(2)P protein, Drosophila

Identifiers

PMID33539341
PMCPMC7888665
OpenAlexW3128935747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.